Consequently, the overexpression of mutant IDH1 or D2HG sensitizes glioma cells to infection by oncolytic viruses such as VSVΔ51, thereby promoting viral replication and enhancing therapeutic efficacy [78]. Here, IDH1 is linked to central nervous system cancer.